Drug Type Small molecule drug |
Synonyms floxacin and Sodium Chloride, Of1oxacin, Ofloxacin (JP17/USP/INN) + [56] |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (16 Apr 1985), |
RegulationOrphan Drug (United States), Orphan Drug (Japan) |
Molecular FormulaC18H20FN3O4 |
InChIKeyGSDSWSVVBLHKDQ-UHFFFAOYSA-N |
CAS Registry82419-36-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infectious Diseases | United States | 16 Dec 1997 | |
Corneal Ulcer | United States | 28 Dec 1990 | |
Trachoma | Japan | 01 Jun 1989 | |
Blepharitis | Japan | 30 Jun 1987 | |
Conjunctivitis | Japan | 30 Jun 1987 | |
Dacryocystitis | Japan | 30 Jun 1987 | |
Hordeolum | Japan | 30 Jun 1987 | |
Keratitis | Japan | 30 Jun 1987 | |
Bacterial Infections | Japan | 16 Apr 1985 | |
Otitis Externa | Japan | 16 Apr 1985 | |
Otitis Media | Japan | 16 Apr 1985 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute otitis media | Phase 3 | - | 01 Nov 2002 |
Not Applicable | 114 | Small incision lenticule extraction+Proxymetacaine 0.5%+Oxybuprocaine 0.4%+Tobramycin and dexamethasone+Ofloxacin | frutsufmaz(cikotbkvwd) = msyimhtfqb dahdvkpuhu (iyjxiwwlqq, 0.48) View more | - | 23 Apr 2024 | ||
Phase 4 | 38 | (DMEK) | vqgdxrrmuq(uqpknxyiex) = hergewbbvs jgybxomwjt (egwodjethd, 0.11) View more | - | 02 Jul 2019 | ||
(DSAEK) | vqdpubtsak(ebnlyouhyw) = bbyezvloen nwrbgujgqi (mhbfohsgeg, 0.136) View more | ||||||
Not Applicable | - | nebweutysn(pfjjkzruxj) = nvrgmtqoov ascryqyjuf (sxvjfameyy, 48 - 216) | - | 23 Jun 2004 | |||
nebweutysn(pfjjkzruxj) = kwteheckua ascryqyjuf (sxvjfameyy, 48 - 262) |